These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 34944559)
1. Sulfated Hyaluronan Modulates the Functional Properties and Matrix Effectors Expression of Breast Cancer Cells with Different Estrogen Receptor Status. Koutsakis C; Tavianatou AG; Kokoretsis D; Baroutas G; Karamanos NK Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944559 [TBL] [Abstract][Full Text] [Related]
2. The action of hyaluronan in functional properties, morphology and expression of matrix effectors in mammary cancer cells depends on its molecular size. Tavianatou AG; Piperigkou Z; Koutsakis C; Barbera C; Beninatto R; Franchi M; Karamanos NK FEBS J; 2021 Jul; 288(14):4291-4310. PubMed ID: 33512780 [TBL] [Abstract][Full Text] [Related]
3. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors. Karalis TT; Heldin P; Vynios DH; Neill T; Buraschi S; Iozzo RV; Karamanos NK; Skandalis SS Matrix Biol; 2019 May; 78-79():118-138. PubMed ID: 29673760 [TBL] [Abstract][Full Text] [Related]
4. Molecular size-dependent specificity of hyaluronan on functional properties, morphology and matrix composition of mammary cancer cells. Tavianatou AG; Piperigkou Z; Barbera C; Beninatto R; Masola V; Caon I; Onisto M; Franchi M; Galesso D; Karamanos NK Matrix Biol Plus; 2019 Aug; 3():100008. PubMed ID: 33543007 [TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells. Bouris P; Skandalis SS; Piperigkou Z; Afratis N; Karamanou K; Aletras AJ; Moustakas A; Theocharis AD; Karamanos NK Matrix Biol; 2015 Apr; 43():42-60. PubMed ID: 25728938 [TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer. Piperigkou Z; Franchi M; Götte M; Karamanos NK Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712 [TBL] [Abstract][Full Text] [Related]
8. Lumican effectively regulates the estrogen receptors-associated functional properties of breast cancer cells, expression of matrix effectors and epithelial-to-mesenchymal transition. Karamanou K; Franchi M; Piperigkou Z; Perreau C; Maquart FX; Vynios DH; Brézillon S Sci Rep; 2017 Mar; 7():45138. PubMed ID: 28332606 [TBL] [Abstract][Full Text] [Related]
9. Serglycin promotes breast cancer cell aggressiveness: Induction of epithelial to mesenchymal transition, proteolytic activity and IL-8 signaling. Bouris P; Manou D; Sopaki-Valalaki A; Kolokotroni A; Moustakas A; Kapoor A; Iozzo RV; Karamanos NK; Theocharis AD Matrix Biol; 2018 Dec; 74():35-51. PubMed ID: 29842969 [TBL] [Abstract][Full Text] [Related]
10. The effects of sulfated hyaluronan in breast, lung and colorectal carcinoma and monocytes/macrophages cells: Its role in angiogenesis and tumor progression. Spinelli FM; Rosales P; Pluda S; Vitale DL; Icardi A; Guarise C; Reszegi A; Kovalszky I; García M; Sevic I; Galesso D; Alaniz L IUBMB Life; 2022 Oct; 74(10):927-942. PubMed ID: 35218610 [TBL] [Abstract][Full Text] [Related]
11. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration. Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740 [TBL] [Abstract][Full Text] [Related]
12. Resveratrol Inhibits the Migration and Metastasis of MDA-MB-231 Human Breast Cancer by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition. Sun Y; Zhou QM; Lu YY; Zhang H; Chen QL; Zhao M; Su SB Molecules; 2019 Mar; 24(6):. PubMed ID: 30901941 [TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor beta modulates breast cancer cells functional properties, signaling and expression of matrix molecules. Piperigkou Z; Bouris P; Onisto M; Franchi M; Kletsas D; Theocharis AD; Karamanos NK Matrix Biol; 2016 Dec; 56():4-23. PubMed ID: 27179695 [TBL] [Abstract][Full Text] [Related]
14. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line. Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370 [TBL] [Abstract][Full Text] [Related]
15. Extracellular alkaline pH leads to increased metastatic potential of estrogen receptor silenced endocrine resistant breast cancer cells. Khajah MA; Almohri I; Mathew PM; Luqmani YA PLoS One; 2013; 8(10):e76327. PubMed ID: 24098477 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of FASN and ERα signalling during hyperglycaemia-induced matrix-specific EMT promotes breast cancer cell invasion via a caveolin-1-dependent mechanism. Zielinska HA; Holly JMP; Bahl A; Perks CM Cancer Lett; 2018 Apr; 419():187-202. PubMed ID: 29331414 [TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of sulfated hyaluronic acid fragments in pre-clinical models of bladder cancer. Jordan AR; Lokeshwar SD; Lopez LE; Hennig M; Chipollini J; Yates T; Hupe MC; Merseburger AS; Shiedlin A; Cerwinka WH; Liu K; Lokeshwar VB Oncotarget; 2017 Apr; 8(15):24262-24274. PubMed ID: 27419371 [TBL] [Abstract][Full Text] [Related]
18. Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition Yu JK; Yue CH; Pan YR; Chiu YW; Liu JY; Lin KI; Lee CJ Anticancer Res; 2018 Apr; 38(4):2127-2135. PubMed ID: 29599331 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells. Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038 [TBL] [Abstract][Full Text] [Related]